GENTIUM SPA GENTIUM SPA ADS ADSS (GENT)

Overview Price 9.02 Price Change Today +$0.22 (+2.50%) P&P rating Zacks Rank 3 - HOLD Open Price $8.78 Previous Close $8.80 Daily Range $8.78 - $9.20 52-Week Range $5.31 - $13.69 Volume 6,525 Gentium, S.p.A., located in Como, Italy, is a biopharmaceutical company focused on the research, development and manufacture of drugs to treat and prevent a variety of vascular diseases and conditions related to cancer and cancer treatments. Defibrotide, the Company's lead product candidate, is an investigational drug that has been granted Track Designation by the U.S. FDA for the treatment of Severe VOD, Orphan Drug status by the U.S. FDA for the treatment and prevention of VOD and Orphan Medicinal Product Designation by the European Commission for the treatment and prevention of VOD. Other Resources for GENT Detailed Quote Earnings Estimates Company Report Interactive Chart Commentary No Commentary Found for This Ticker. Gentium, S.p.A., located in Como, Italy, is a biopharmaceutical company focused on the research, development and manufacture of drugs to treat and prevent a variety of vascular diseases and conditions related to cancer and cancer treatments. Defibrotide, the Company's lead product candidate, is an investigational drug that has been granted Track Designation by the U.S. FDA for the treatment of Severe VOD, Orphan Drug status by the U.S. FDA for the treatment and prevention of VOD and Orphan Medicinal Product Designation by the European Commission for the treatment and prevention of VOD.   Brokerage Analyst Recommendations 2 Brokerage Firms Covering GENT   Strong Buy 1 Buy 0 Hold 0 Sell 0 Strong Sell 1 Average Broker Recommendation (ABR): 3   GENT Ratings: BUY  SELL  HOLD GENT Consensus Forecasts

Rate this Stock! You haven't rated this stock yet! Ticker Call Buy Sell Analysis Time Frame Week or Less Week to a Month One to Three Months Three to Six Months Six Months to a Year One to Three Years Three Plus Years What The Community Thinks Total Players 4 Buy 0 Sell   Top Buy Analysis No Buy Analysis. Be the First. More Recent Analysis Top Sell Analysis No Sell Analysis. Be the First. More Recent Analysis

Blog Posts

No related Blog Posts.

Commentary

BUY: GENTIUM SPA - GENTIUM SPA AMERICAN D (GENT) Start Price: $9.89 Points: -10.92 Created: 06/30/2011 Comments: 0 | Comment dmonnie Recs:

BUY: GENTIUM SPA - GENTIUM SPA AMERICAN D (GENT) Start Price: $19.04 Points: -44.50 Created: 01/01/2008 Comments: 0 | Comment idahok Recs:

BUY: GENTIUM SPA - GENTIUM SPA AMERICAN D (GENT) Start Price: $10.10 Points: -2.57 Created: 01/01/2008 Comments: 0 | Comment Belmonty Recs:

BUY: GENTIUM SPA - GENTIUM SPA AMERICAN D (GENT) Start Price: $18.01 Points: -41.79 Created: 01/01/2008 Comments: 0 | Comment ledoux Recs:

Picks

Username	P&P Score	Call	Time Frame	Start Date	Start Price	Today (change)	Stock Gain	S&P Gain	Points	Analysis
dmonnie	0.21	BUY	One to Three Months	06/30/2011	$9.89	$9.02 (+3.68%)	-8.80%	+2.13%	-10.92
idahok	28.54	BUY	Six Months to a Year	01/01/2008	$19.04	$9.02 (+3.68%)	-52.63%	-8.12%	-44.50
Belmonty	27.15	BUY	Six Months to a Year	01/01/2008	$10.10	$9.02 (+3.68%)	-10.69%	-8.12%	-2.57
ledoux		BUY	Six Months to a Year	01/01/2008	$18.01	$9.02 (+3.68%)	-49.92%	-8.12%	-41.79